As part of our In Profile series, unquote" takes a look at Vitruvian Partners' recent activity and what lies ahead for the UK-based GP.
GP will become a majority shareholder in the group, with the deal expected to complete later this year
EchoVC+, TPG/Satya, NEA and Partech Ventures also took part in the funding round
Deal should be sealed by June 2017, with BlueGem aquiring shares from the founders and family office SEP
Investment will fund international expansion, with a particular focus on the Latin American market